Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Hellmuth Weich
Added:
3 years ago
There has been a recent explosion in the field of transcatheter aortic and pulmonary valve replacements, but the atrio-ventricular valves have lagged behind for various reasons with the tricuspid valve undoubtedly the least treated valve of the four. Despite the fact that tricuspid regurgitation (TR) can result in significant symptoms, patients are rarely referred for isolated surgical tricuspid…
View more
Author(s):
Sameer Gafoor
Added:
7 years ago
Sameer Gafoor discusses "Transcathether Tricuspid Valve Technologies" at the 2016 PCR London Valves Congress in London, UK.
View more
Author(s):
Stephan Baldus
Added:
1 year ago
Prof Stephan Baldus (University of Köln Medical Center, DE) shares insights from the TriCLASP post-market study (NCT04614402).
This postmarket clinical follow up study, presented at EuroPCR 2022, assessed the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter tricuspid valve repair.
Discussion Points:
1. Unmet needs of patients with TR
2. Study…
View more
Tricuspid Regurgitation: A Clinical Case-Based Review Of The Edwards Cardioband™ Tricuspid Valve…
Author(s):
Stephan Baldus
Added:
5 years ago
Article
Author(s):
Yan Topilsky
Added:
3 years ago
In contrast to aortic or mitral diseases, there has been far less discussion on indications for tricuspid valve repair or replacement. Despite the fact that tricuspid regurgitation (TR) can result in significant symptoms, it remains undertreated. Patients are rarely referred for isolated surgical repair, or replacement, and most surgeries are performed in the context of other planned cardiac…
View more
Author(s):
Christian Besler
,
Christopher U Meduri
,
Philipp Lurz
Added:
3 years ago
Accumulating evidence suggests that tricuspid regurgitation (TR) is independently associated with reduced long-term survival in the community and patients with ischaemic or dilated cardiomyopathy.1 Patients with moderate-to-severe TR suffer symptoms of progressive right heart failure, which are often difficult to treat with diuretic therapy. Prevalence estimates based on data from the Framingham…
View more
Author(s):
Jonathan Curio
,
Ozan M Demir
,
Matteo Pagnesi
,
et al
Added:
3 years ago
Tricuspid regurgitation (TR) is common, affecting 5% of the elderly population and, when its severity reaches moderate to severe, is an independent predictor of increased mortality.1–3 The pathophysiology of TR is mainly functional as it occurs in the context of pulmonary hypertension, left-sided heart disease and AF.4 These lead to deformation of the right ventricle (RV) and the right atrium (RA…
View more
Author(s):
Paul Sorajja
,
Ralph Stephan von Bardeleben
,
Gilbert Tang
,
et al
Start date:
May 11, 2023
View more
Author(s):
Maurizio Taramasso
,
Christelle Calen
,
Andrea Guidotti
,
et al
Added:
3 years ago
The leading aetiology of tricuspid regurgitation (TR) in developed countries is functional, secondary to left side heart disease and pulmonary hypertension.1 Currently, moderate-to-severe TR affects approximately 1.6 million patients in the United States, of whom only 8,000 undergo tricuspid surgery annually;2 this results in an extremely large number of untreated patients with significant TR, a…
View more